| Product NDC: | 61442-175 |
| Proprietary Name: | Cefaclor |
| Non Proprietary Name: | Cefaclor |
| Active Ingredient(s): | 250 mg/5mL & nbsp; Cefaclor |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61442-175 |
| Labeler Name: | Carlsbad Technology, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065412 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120327 |
| Package NDC: | 61442-175-01 |
| Package Description: | 150 mL in 1 BOTTLE, PLASTIC (61442-175-01) |
| NDC Code | 61442-175-01 |
| Proprietary Name | Cefaclor |
| Package Description | 150 mL in 1 BOTTLE, PLASTIC (61442-175-01) |
| Product NDC | 61442-175 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cefaclor |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20120327 |
| Marketing Category Name | ANDA |
| Labeler Name | Carlsbad Technology, Inc. |
| Substance Name | CEFACLOR |
| Strength Number | 250 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |